You have 9 free searches left this month | to do more
Showing 1 - 25 of
556 items
Trials Per Page
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
H
Anlotinib Combination With Vinorelbine in the HER2- Advanced Breast Cancer
Not yet recruiting
  • Breast Cancer
  • anlotinib and vinorelbine
  • Vinorelbine injection
  • Zhengzhou, Henan, China
    Henan Cancer Hospital
2022-03-16
Mar 16, 2022
C
Vinorelbine for Recurrent ALCL-2017
Recruiting
  • Anaplastic Large Cell Lymphoma
  • Vinorelbine
  • Vinorelbine
  • Shanghai, Shanghai, China
    Shanghai Children's Medical Center
2021-07-28
Jul 28, 2021
J
Mocetinostat With Vinorelbine in Children, Adolescents & Young Adults With Refractory and/or Recurrent Rhabdomyosarcoma
Recruiting
  • Rhabdomyosarcoma
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
2022-03-17
Mar 17, 2022
W
Vinorelbine in Mesothelioma - 2021
Completed
  • Mesothelioma
  • Vinorelbine
  • Active Symptom Control
  • Cardiff, United Kingdom
    Wales Cancer Trials Unit
2021-10-04
Oct 4, 2021
T
Pyrotinib Maleate Combined With Vinorelbine in the Treatment of HER2-positive Advanced Breast Cancer - 2022
Completed
  • HER2-positive Advanced Breast Cancer
  • Pyrotinib Maleate
  • Vinorelbine
  • Tianjin, China
    Tianjin Cancer Hospital
2022-04-06
Apr 6, 2022
C
Safety and Efficacy of Toripalimab in HER2- Metastatic Breast Cancer Patients Treated With Metronomic Vinorelbine
Recruiting
  • Metastatic Breast Cancer
  • Vinorelbine 40mg
  • +5 more
  • Beijing, Beijing, China
  • +1 more
2022-02-09
Feb 9, 2022
Z
Cipterbin Combined With Vinorelbine in the Treatment of HER2-positive MBC
Recruiting
  • Metastatic Breast Cancer
  • Cipterbin Combined With Vinorelbine
  • Hangzhou, Zhejiang, China
    Zhejiang Cancer Hospital
2021-11-11
Nov 11, 2021
A
Surufatinib or Surufatinib Combined With Vinorelbine for Non-Small Cell Lung Cancer
Recruiting
  • Advanced Non-Small Cell Lung Cancer
  • Guangzhou, Guangdong, China
    Affiliated Cancer Hospital and Institute of Guangzhou Medical Un
2021-08-10
Aug 10, 2021
P
Efficacy and Safety of Combinition of Camrelizumab in Second-line Neoadjuvant Chemotherapy and Adjuvant Therapy
Recruiting
  • HER2-negative Breast Cancer
  • +5 more
  • Camrelizumab with vinorelbine and cisplatin
  • Beijing, Beijing, China
    Peking University First Hospital
2021-11-27
Nov 27, 2021
T
Dose-escalation Study of Intravenous Liposomal Vinorelbine Tartrate Injection in Patients With Advanced Malignancy - 2020
Completed
  • Cancer
  • Detroit, Michigan
  • +2 more
2021-07-22
Jul 22, 2021
F
Pyrotinib Plus Vinorelbine Versus Lapatinib Plus Capecitabine - 2021
Completed
  • Breast Cancer
    • Shanghai, China
      Fudan University Shanghai Cancer Center
    2021-08-05
    Aug 5, 2021
    Z
    Pyrotinib and Vinorelbine Tartrate Capsules With or Without Inetetamab for First Line Treatment in Patients With Trastuzumab-resistant HER2-positive Advanced Breast Cancer
    Not yet recruiting
    • Metastatic Breast Cancer
    • (no location specified)
    2021-07-11
    Jul 11, 2021
    F
    Pyrotinib Plus Vinorelbine in HER2+ Metastatic Breast Cancer Patients - 2021
    Completed
    • Breast Cancer
      • Shanghai, Shanghai, China
        Fudan University Shanghai Cancer Center
      2021-06-17
      Jun 17, 2021
      S
      Pyrotinib Plus Vinorelbine in Participants With HER2-positive Previously Treated Locally Advanced or Metastatic Breast Cancer
      Recruiting
      • Breast Cancer
      • +4 more
      • Pyrotinib 320mg + Vinorelbine
      • +2 more
      • Guangzhou, China
        Zhang Jingmin
      2020-10-22
      Oct 22, 2020
      U
      Metronomic Oral Vinorelbine Plus Anti-PD-L1/Anti-CTLA4 ImmunothErapy in Patients With Advanced Solid Tumours
      Active, not recruiting
      • Advanced Solid Tumours
      • +4 more
      • Durvalumab + Tremelimumab + metronomic Vinorelbine
      • Angers, France
      • +8 more
      2022-01-28
      Jan 28, 2022
      I
      GVM±R in Patients With Relapsed or Refractory Aggressive NHL
      Not yet recruiting
      • Non Hodgkin Lymphoma
      • Liposomal Mitoxantrone Hydrochloride dose level 1
      • +6 more
      • (no location specified)
      2022-03-17
      Mar 17, 2022
      H
      A Study of L-DOS47 in Combination With Vinorelbine/Cisplatin in Lung Adenocarcinoma - 2020
      Terminated
      • Lung Adenocarcinoma
      • Otwock, Poland
      • +3 more
      2021-08-23
      Aug 23, 2021
      F
      Vinorelbine Plus Apatinib Versus Vinorelbine in Advanced Triple-Negative Breast Cancer
      Recruiting
      • Advanced Triple-Negative Breast Cancer
      • Shanghai, China
        Fudan University Cancer Hospital
      2020-07-21
      Jul 21, 2020
      C
      A Open Study of Metronomic Oral Vinorelbine in Combination With Aromatase Inhibitors for the Treatment of Postmenopausal Women With Hormone Receptor Positive,HER2-negative, Advanced Breast Cancer Who Received no Prior Therapy for Advanced Disease - 2020
      Terminated
      • Breast Cancer
      • Besançon, France
        CHU Besançon
      2021-01-29
      Jan 29, 2021
      V
      Tocotrienol as a Nutritional Supplement in Patients With Advanced Lung Cancer - 2021
      Terminated
      • Lung Cancer
      • Day 1: Cisplatin 75 mg/m2
      • +7 more
      • Vejle, Denmark
        Department of Oncology, Vejle Hospital
      2021-04-28
      Apr 28, 2021
      U
      Trial to Evaluate Safety and Efficacy of Vinorelbine With Metronomic Administration in Combination With Atezolizumab as Second-line Treatment for Patients With Stage IV Non-small Cell Lung Cancer
      Active, not recruiting
      • Non-small Cell Lung Cancer
      • Aix-en-Provence, France
      • +12 more
      2022-03-03
      Mar 3, 2022
      S
      Study With Atezolizumab in Combination With Trastuzumab and Vinorelbine in HER2-positive Advanced/Metastatic Breast Cancer
      Recruiting
      • Breast Cancer
      • Atezolizumab + Trastuzumab + Vinorelbine
      • Granada, Andalucía, Spain
      • +14 more
      2022-03-02
      Mar 2, 2022
      A
      The AVIATOR Study: Trastuzumab and Vinorelbine With Avelumab OR Avelumab & Utomilumab in Advanced HER2+ Breast Cancer
      Recruiting
      • Breast Cancer
      • Vinorelbine
      • +3 more
      • Birmingham, Alabama
      • +16 more
      2022-03-28
      Mar 28, 2022
      S
      PD-1 Inhibitor or PD-1 Inhibitor Plus GVD for Relapsed/Refractory CHL
      Recruiting
      • Classical Hodgkin Lymphoma
      • Refractory or Relapsed Classical Hodgkin Lymphoma
      • PD-1 inhibitor
      • PD-1 inhibitor, gemcitabine, vinorelbine and doxorubicin liposome
      • Guangzhou, Guangdong, China
      • +2 more
      2021-04-17
      Apr 17, 2021
      J
      Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With B-cell Non-Hodgkin's Lymphoma That Has Relapsed Following Peripheral Stem Cell Transplantation - 2005
      Completed
      • Lymphoma
      • rituximab
      • vinorelbine ditartrate
      • Los Angeles, California
        Jonsson Comprehensive Cancer Center, UCLA
      2020-07-30
      Jul 30, 2020